Dr. Kavya Dendukuri | Hepatology Specialist in Chennai | Dr. Rela Institute, India

Dr. Kavya Dendukuri

MBBS, MD (Internal Medicine), DM, Post Doctoral Fellowship in Transplant

Consultant

Hepatology, Medical Gastroenterology

Chennai

Educational Qualifications

  • MediCiti Institute of Medical Sciences, MBBS 2008
  • Navodaya Medical College Hospital, Raichur, India, MD Internal Medicine, 2012
  • Sri Ramachandra University, Chennai, DM Medical Gastroenterology & Hepatology, 2015
  • Global Health City, Chennai, PDF in Transplant Hepatology, 2017
 

Experience

  • Global Health City, Consultant Hepatologist, March 2017-September 2018

Research & Publication

Posters:

  • Isolated Small Terminal Ileal Ulcers- Diagnostic Utility of Endoscopic Biopsies in MIDTERM ISGCON- 2014, Coimbatore. India.

Oral Presentations:

  • Presented a rare case of Hepatitis C at Singapore Hepatitis Conference- Best of EASL- May 2016.
  • Presented a case at a CME- February - 2016, Chennai, India.
  • Presented case series on Isolated Small Terminal Ileal Ulcers. Diagnostic Utility of Endoscopic Biopsies at MIDTERM ISGCON- 2014, Coimbatore
  • Presented a case of recurrent AIH in Post-transplant setting at MCLD, Jan-2017, Chennai.

Scientific Publications Published:

  • Kavya Harika Dendukuri, Shanti Vijayaraghavan. Isolated Small Terminal Ileal Ulcers- Diagnostic Utility of Endoscopic Biopsies. Journal of Evidence based Medicine and Health Care. Issue 30, July 27, 2015.
  • H Pavan, Joy V, Kavya Harika et al - Case Report on Malignant Hepatic EpitheloidHemangioendothelioma with Villaret syndrome- Journal of Clinical and Experimental Hepatology – September 28th 2016.
  • HRQL using SF36 (Generic Specific) in liver cirrhsosis – Indian Journal of Gastroentrology.
  • Cryptogenic cirrhosis - Mystery decoded on explant evaluation.
  • Explant liver opening a Pandora`s box.
  • Therapeutic plasma exchange as an adjuent to supportive management in ESLD patients with high MELD score > 25, awaiting Liver Transplantation. Journal of Clinical & Experimental Hepatology. 6(1); S36 July 2016
  • Combination of TACE & Sorafenib improve outcomes in BCLC stage B/C of Hepatocellular Carcinoma. A single centre Experience.
 

To seek a quick appointment

Copyrights © 2021 Rela Institute & Medical Centre. All Rights Reserved.